key: cord-0872047-43q01ap4 authors: Motzkus, Christine A; Whitaker, Nash; Lommel, Jennifer; Pettit, Nicholas title: Multisystem inflammatory syndrome in adults: A case in a previously healthy adult date: 2021-10-18 journal: J Am Coll Emerg Physicians Open DOI: 10.1002/emp2.12426 sha: 72b431fc3ee54398f8c880d6d693b255842f7f5f doc_id: 872047 cord_uid: 43q01ap4 A 25‐year‐old previously healthy female presented to the emergency department (ED) with 5 days of rash, fevers, shortness of breath, and generalized weakness. She had presented to another ED 4 days previously and noted that her rash had improved, but her other symptoms were worsening. She had recovered from COVID‐19, confirmed by positive antigen test 5 weeks prior. On ED arrival, she was afebrile and persistently tachycardic to a rate of 120 beats per minute, despite aggressive fluid resuscitation with 3L of IV crystalloid. She was found to have a troponin elevated to 0.06 ng/mL in addition to a d‐dimer elevated to 1.42 mcg/mL FEU. She was admitted to the hospital where she developed hypotension requiring vasopressor support and was admitted to the intensive care unit (ICU). A transthoracic echocardiogram revealed a newly reduced ejection fraction of 31%. She was diagnosed with multisystem inflammatory syndrome in adults (MIS‐A). The patient received intravenous immunoglobulin and methylprednisolone 60 mg Q12 hours while admitted. She was discharged on hospital day 3 with a prednisone taper and is currently doing well at her most recent follow‐up with infectious disease. (2) positive test result for SARS-CoV2 within the previous 12 weeks, (3) severe dysfunction of extrapulmonary organ systems, (4) elevated inflammatory markers, and (5) absence of severe respiratory illness. 4 We present a case of MIS-A in a previously healthy young adult patient. An otherwise healthy 25-year-old female contacted her primary care physician in mid-October with 9 days of congestion, anosmia, She presented to care in the emergency department 5 weeks later with 2 days of shortness of breath, fevers, sore throat, weakness, and rash. At that time, she was overall well appearing and had laboratory testing that included negative flu, negative strep, and unremarkable basic metabolic panel and complete blood count. She had some improvement in her symptoms with IV fluids and was discharged home with supportive care measures. Repeat SARS-CoV-2 antigen testing was negative. She was evaluated again at a telemedicine primary care visit 2 days later where she was noted to have visible maculopapular rash with swelling of her hands and feet (Figures 1 and 2) . She was noted not to be in acute distress and instructed to continue supportive care measures at home. She presented to another ED 2 days later. At that time, she was noted to be tachycardic with a maximal heart rate of 130 beats per minute, without an associated fever. She endorsed multiple days of diarrhea, ongoing shortness of breath and myalgias, and resolving rash. She endorsed dyspnea severity to the point it was causing her difficulty caring for her young children. While in the ED, she received 3L of IV fluids. She was noted to have an elevated d-dimer with subsequently negative computed tomography pulmonary embolus study and a mildly elevated troponin to 0.06 ng/mL. Her tachycardia did not improve while in the ED, and she subsequently developed a fever. She was discharged with a steroid taper. We have no comorbidities at all, similar to our patient, raising concern that this is a disease process that can have serious impacts on young, otherwise healthy individuals' function. 4 To date, the pathophysiology of MIS-A or MIS-C is not understood. Multiple proposed mechanisms exist including endothelial dysfunction and dysregulated immune response among others. 6 These pathways are relatively similar to other proinflammatory disease processes and emphasize COVID-19 as a proinflammatory and prothrombotic disease process with long-reaching effect We want to emphasize the relatively benign presentation of this patient to the ED. Aside from tachycardia, her initial vital signs were not markedly abnormal on her ED presentation before the visit where she was admitted. It is important for frontline physicians to maintain a high level of suspicion for this disease process, especially in young, otherwise healthy people. Persistent tachycardia, despite resuscitative efforts should be a reminder to consider more sinis- ter pathologies in what otherwise may appear to be a simple viral illness. In summary, we present a case of a novel disease process, MIS-A, in a young, healthy patient. As we treat more COVID-19 survivors during the ongoing COVID-19 pandemic, we should maintain a high level of suspicion for post-COVID complications. COVID-19 as the leading cause of death in the United States Multisystem inflammatory syndrome in U.S. children and adolescents Cardiogenic shock and hyperinflammatory syndrome in young males with COVID-19. Circ Hear Fail Case series of multisystem inflammatory syndrome in adults associated with SARS-CoV-2 infection -United Kingdom and United States A young adult with COVID-19 and multisystem inflammatory syndrome in children (MIS-C)-like illness: a case report Vander Heide RS. Cardiac endotheliitis and multisystem inflammatory syndrome after COVID-19 Multisystem inflammatory syndrome in adults: A case in a previously healthy adult The authors declare no conflict of interest. Christine A Motzkus MD, PhD https://orcid.org/0000-0002-6041-2328